Table 5 Convergent validity estimates for the MEX benefits and barriers subscales and existing scales
Scale | N | M (SD) | Benefits r | Barriers r | Fisher’s Z |
|---|---|---|---|---|---|
Sample 1 | |||||
MEX-Benefits | 492 | 46.8 (6.96) | – | – | – |
MEX-Barriers | 492 | 35.8 (11.7) | 0.1*✝ | – | – |
DASS-Depression | 466 | 16.9 (12.6) | 0.03 | 0.725*** | 12.314*** |
DASS-Anxiety | 457 | 17.3 (13.7) | 0.111* | 0.703*** | 10.51*** |
DASS-Stress | 462 | 16.9 (11.6) | 0.093* | 0.707*** | 10.881*** |
SWLS | 482 | 22.8 (7.26) | 0.271*** | 0.092* | 2.719** |
MET·mins/week | 344 | 2972 (2102) | 0.276*** | 0.164** | 1.407 |
SPAF | 480 | 13.2 (3.42) | 0.377*** | 0.097* | 4.363*** |
SDE | 492 | 4.15 (0.782) | 0.149** | −0.337*** | 7.462*** |
IM | 492 | 4.21 (0.822) | −0.018 | −0.254*** | 3.582*** |
Sample 2/3 | |||||
MEX-Benefits | 605 | 45.8 (7.58) | – | – | – |
MEX-Barriers | 605 | 35.6 (8.83) | −0.454*** | – | – |
MASQ-AA | 605 | 28.1 (10.1) | −0.033 | 0.306*** | 5.003*** |
MASQ-AD | 605 | 97.5 (12.0) | −0.195*** | 0.466*** | 10.086*** |
MASQ-GDD | 605 | 30.1 (11.1) | −0.174*** | 0.464*** | 9.721*** |
MASQ-GDA | 605 | 23.2 (7.56) | −0.107** | 0.394*** | 7.527*** |
MASQ-GDM | 605 | 38.9 (11.9) | −0.154*** | 0.459*** | 9.337*** |
SPAF | 605 | 10.9 (3.18) | 0.437*** | −0.606*** | 16.823*** |
LTSES | 605 | 0.815 (0.99) | 0.335*** | −0.451*** | 11.998*** |